Share on StockTwits
 

Cardinal Health (NYSE:CAH) Director Gregory B. Kenny sold 18,175 shares of the stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $65.39, for a total value of $1,188,463.25. Following the completion of the transaction, the director now directly owns 19,584 shares of the company’s stock, valued at approximately $1,280,598. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Cardinal Health (NYSE:CAH) traded down 0.29% during mid-day trading on Wednesday, hitting $65.37. 2,599,201 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $41.42 and a 52 week high of $69.51. The stock has a 50-day moving average of $67.12 and a 200-day moving average of $58.66. The company has a market cap of $22.357 billion and a price-to-earnings ratio of 60.20.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.79 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.84 by $0.05. The company had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $20.74 billion. On average, analysts predict that Cardinal Health will post $3.82 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of 0.3025 per share. This represents a $1.21 dividend on an annualized basis and a yield of 1.85%.

A number of analysts have recently weighed in on CAH shares. Analysts at Zacks reiterated an “outperform” rating on shares of Cardinal Health in a research note to investors on Tuesday. They now have a $83.00 price target on the stock. Separately, analysts at Sterne Agee raised their price target on shares of Cardinal Health from $73.00 to $83.00 in a research note to investors on Friday, January 31st. Finally, analysts at Raymond James raised their price target on shares of Cardinal Health from $75.00 to $77.00 in a research note to investors on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $67.36.

Cardinal Health, Inc is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.